Ed Arce

Ed Arce is a seasoned financial professional with extensive experience in equity research, particularly in the biopharmaceutical and specialty pharmaceutical sectors. Currently serving as a Senior Research Analyst at H.C. Wainwright & Co., LLC since July 2015, Ed specializes in sell-side coverage of small- to mid-cap companies across various therapeutic areas, including nephrology and infectious diseases. Previous roles include Senior Research Analyst at Roth Capital Partners and Life Sciences Analyst at MLV & Co., along with experience at Wedbush Morgan Securities and UBS Investment Bank. Ed's educational background includes a Master of Science in Finance from Boston College and an MBA in General Management from Florida International University, complemented by a Bachelor’s degree in Civil Engineering.